Annual CFF
$428.90 M
+$156.57 M+57.49%
December 31, 2022
Summary
- As of February 10, 2025, ISEE annual cash flow from financing activities is $428.90 million, with the most recent change of +$156.57 million (+57.49%) on December 31, 2022.
- During the last 3 years, ISEE annual CFF has risen by +$386.07 million (+901.23%).
Performance
ISEE Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFF
$2.59 M
-$371.72 M-99.31%
March 31, 2023
Summary
- As of February 10, 2025, ISEE quarterly cash flow from financing activities is $2.59 million, with the most recent change of -$371.72 million (-99.31%) on March 31, 2023.
- Over the past year, ISEE quarterly CFF has increased by +$509.00 thousand (+24.47%).
Performance
ISEE Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFF
$429.41 M
+$509.00 K+0.12%
March 31, 2023
Summary
- As of February 10, 2025, ISEE TTM cash flow from financing activities is $429.41 million, with the most recent change of +$509.00 thousand (+0.12%) on March 31, 2023.
- Over the past year, ISEE TTM CFF has increased by +$155.13 million (+56.56%).
Performance
ISEE TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
ISEE Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +57.5% | +24.5% | +56.6% |
| 3 y3 years | +901.2% | +1346.4% | +899.2% |
| 5 y5 years | +10000.0% | +9488.9% | +902.4% |
ISEE Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | -36.5% | -99.3% | -19.7% | at high | -49.3% |
| 5 y | 5-year | at high | -90.0% | -99.3% | -95.1% | at high | -99.8% |
| alltime | all time | at high | -100.0% | -99.3% | -100.0% | at high | -100.0% |
IVERIC Bio Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | $2.59 M(-99.3%) | $429.41 M(+0.1%) |
| Dec 2022 | $428.90 M(+57.5%) | $374.31 M(+652.8%) | $428.90 M(+97.2%) |
| Sep 2022 | - | $49.72 M(+1675.0%) | $217.51 M(-21.4%) |
| Jun 2022 | - | $2.80 M(+34.7%) | $276.64 M(+0.9%) |
| Mar 2022 | - | $2.08 M(-98.7%) | $274.29 M(+0.7%) |
| Dec 2021 | $272.33 M(+80.9%) | $162.91 M(+49.7%) | $272.33 M(+148.6%) |
| Sep 2021 | - | $108.85 M(>+9900.0%) | $109.56 M(>+9900.0%) |
| Jun 2021 | - | $448.00 K(+247.3%) | $852.00 K(-99.4%) |
| Mar 2021 | - | $129.00 K(+0.8%) | $150.53 M(-0.0%) |
| Dec 2020 | $150.58 M(+251.5%) | $128.00 K(-12.9%) | $150.58 M(-22.1%) |
| Sep 2020 | - | $147.00 K(-99.9%) | $193.21 M(+0.1%) |
| Jun 2020 | - | $150.13 M(>+9900.0%) | $193.10 M(+349.3%) |
| Mar 2020 | - | $179.00 K(-99.6%) | $42.98 M(+0.3%) |
| Dec 2019 | $42.84 M(+597.7%) | $42.76 M(>+9900.0%) | $42.84 M(+595.9%) |
| Sep 2019 | - | $40.00 K(>+9900.0%) | $6.16 M(+0.0%) |
| Jun 2019 | - | $0.00(-100.0%) | $6.15 M(0.0%) |
| Mar 2019 | - | $41.00 K(-99.3%) | $6.15 M(+0.2%) |
| Dec 2018 | $6.14 M(+8547.9%) | $6.08 M(>+9900.0%) | $6.14 M(+9346.2%) |
| Sep 2018 | - | $38.00 K(>+9900.0%) | $65.00 K(+25.0%) |
| Jun 2018 | - | $0.00(-100.0%) | $52.00 K(-22.4%) |
| Mar 2018 | - | $27.00 K(>+9900.0%) | $67.00 K(-5.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2017 | $71.00 K(-99.0%) | $0.00(-100.0%) | $71.00 K(-95.6%) |
| Sep 2017 | - | $25.00 K(+66.7%) | $1.61 M(-49.3%) |
| Jun 2017 | - | $15.00 K(-51.6%) | $3.17 M(-48.8%) |
| Mar 2017 | - | $31.00 K(-98.0%) | $6.20 M(-10.6%) |
| Dec 2016 | $6.93 M(-45.7%) | $1.54 M(-3.4%) | $6.93 M(-42.9%) |
| Sep 2016 | - | $1.59 M(-47.7%) | $12.15 M(-1.8%) |
| Jun 2016 | - | $3.04 M(+295.8%) | $12.37 M(+5.0%) |
| Mar 2016 | - | $768.00 K(-88.6%) | $11.78 M(-7.8%) |
| Dec 2015 | $12.78 M(-91.2%) | $6.75 M(+272.6%) | $12.78 M(-75.1%) |
| Sep 2015 | - | $1.81 M(-26.1%) | $51.34 M(-0.4%) |
| Jun 2015 | - | $2.45 M(+39.3%) | $51.54 M(+1.8%) |
| Mar 2015 | - | $1.76 M(-96.1%) | $50.62 M(-65.3%) |
| Dec 2014 | $145.95 M(-42.8%) | $45.31 M(+2152.2%) | $145.95 M(+44.9%) |
| Sep 2014 | - | $2.01 M(+31.2%) | $100.73 M(-67.3%) |
| Jun 2014 | - | $1.53 M(-98.4%) | $307.71 M(-12.3%) |
| Mar 2014 | - | $97.09 M(>+9900.0%) | $350.73 M(+37.5%) |
| Dec 2013 | $255.07 M(+2216.3%) | $94.00 K(-100.0%) | $255.07 M(+0.0%) |
| Sep 2013 | - | $208.99 M(+369.1%) | $254.98 M(+454.5%) |
| Jun 2013 | - | $44.55 M(+3015.7%) | $45.98 M(+3115.7%) |
| Mar 2013 | - | $1.43 M | $1.43 M |
| Dec 2012 | $11.01 M(-26.6%) | - | - |
| Dec 2011 | $14.99 M | - | - |
FAQ
- What is IVERIC bio annual cash flow from financing activities?
- What is the all time high annual CFF for IVERIC bio?
- What is IVERIC bio annual CFF year-on-year change?
- What is IVERIC bio quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for IVERIC bio?
- What is IVERIC bio quarterly CFF year-on-year change?
- What is IVERIC bio TTM cash flow from financing activities?
- What is the all time high TTM CFF for IVERIC bio?
- What is IVERIC bio TTM CFF year-on-year change?
What is IVERIC bio annual cash flow from financing activities?
The current annual CFF of ISEE is $428.90 M
What is the all time high annual CFF for IVERIC bio?
IVERIC bio all-time high annual cash flow from financing activities is $428.90 M
What is IVERIC bio annual CFF year-on-year change?
Over the past year, ISEE annual cash flow from financing activities has changed by +$156.57 M (+57.49%)
What is IVERIC bio quarterly cash flow from financing activities?
The current quarterly CFF of ISEE is $2.59 M
What is the all time high quarterly CFF for IVERIC bio?
IVERIC bio all-time high quarterly cash flow from financing activities is $374.31 M
What is IVERIC bio quarterly CFF year-on-year change?
Over the past year, ISEE quarterly cash flow from financing activities has changed by +$509.00 K (+24.47%)
What is IVERIC bio TTM cash flow from financing activities?
The current TTM CFF of ISEE is $429.41 M
What is the all time high TTM CFF for IVERIC bio?
IVERIC bio all-time high TTM cash flow from financing activities is $429.41 M
What is IVERIC bio TTM CFF year-on-year change?
Over the past year, ISEE TTM cash flow from financing activities has changed by +$155.13 M (+56.56%)